The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice

Microbial Pathogenesis

Volumn 51, Issue 3, 2011, Pages 217-224

  Tuomainen, Anita M ^a,f   Hyvärinen, Kati ^a,f   Ehlers, Pauliina I ^b   Mervaala, Eero ^b   Leinonen, Maija ^c   Saikku, Pekka ^d   Kovanen, Petri T ^e   Jauhiainen, Matti ^a,c   Pussinen, Pirkko J ^a,f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e WIHURI RESEARCH INSTITUTE   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Infection; Inflammation; Mouse model; Periodontitis

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN E; BACTERIUM LIPOPOLYSACCHARIDE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; PHOSPHOLIPID TRANSFER PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HOST PATHOGEN INTERACTION; MALE; MESENTERY BLOOD FLOW; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT;

ANIMALS; APOLIPOPROTEINS E; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HOMEOSTASIS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PASTEURELLACEAE; PASTEURELLACEAE INFECTIONS; PHOSPHOLIPID TRANSFER PROTEINS; RATS; SERUM; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

CHLAMYDOPHILA PNEUMONIAE; MUS; RATTUS;

EID: 79959356248     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.03.003     Document Type: Article

References (63)

1. Beck J.D., Eke P., Heiss G., Madianos P., Couper D., Lin D., et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 2005, 112:19-24.
2. Sakurai K., Wang D., Suzuki J., Umeda M., Nagasawa T., Izumi Y., et al. High incidence of actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J 2007, 48:663-675.
3. Pussinen P.J., Jousilahti P., Alfthan G., Palosuo T., Asikainen S., Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol 2003, 23:1250-1254.
4. Pussinen P.J., Alfthan G., Tuomilehto J., Asikainen S., Jousilahti P. High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004, 11:408-411.
5. Pussinen P.J., Alfthan G., Rissanen H., Reunanen A., Asikainen S., Knekt P. Antibodies to periodontal pathogens and stroke risk. Stroke 2004, 35:2020-2023.
6. Pussinen P.J., Nyyssonen K., Alfthan G., Salonen R., Laukkanen J.A., Salonen J.T. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 2005, 25:833-838.
7. Pussinen P.J., Tuomisto K., Jousilahti P., Havulinna A.S., Sundvall J., Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007, 27:1433-1439.
8. Pussinen P.J., Alfthan G., Jousilahti P., Paju S., Tuomilehto J. Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis 2007, 193:222-228.
9. Li L., Messas E., Batista E.L., Levine R.A., Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002, 105:861-867.
10. Lalla E., Lamster I.B., Hofmann M.A., Bucciarelli L., Jerud A.P., Tucker S., et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003, 23:1405-1411.
11. Gibson F.C., Hong C., Chou H.H., Yumoto H., Chen J., Lien E., et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004, 109:2801-2806.
12. Tuomainen A.M., Jauhiainen M., Kovanen P.T., Metso J., Paju S., Pussinen P.J. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathog 2008, 44:111-117.
13. Oksaharju A., Lappalainen J., Tuomainen A.M., Pussinen P.J., Puolakkainen M., Kovanen P.T., et al. Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J Cell Mol Med 2009, 13:103-113.
14. Geerts S.O., Nys M., De M.P., Charpentier J., Albert A., Legrand V., et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 2002, 73:73-78.
15. Wiedermann C.J., Kiechl S., Dunzendorfer S., Schratzberger P., Egger G., Oberhollenzer F., et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999, 34:1975-1981.
16. Moazed T.C., Kuo C.C., Grayston J.T., Campbell L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998, 177:1322-1325.
17. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986.
18. Lajunen T., Vikatmaa P., Ikonen T., Lepantalo M., Lounatmaa K., Sormunen R., et al. Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques. Diagn Microbiol Infect Dis 2008, 61:156-164.
19. Leinonen M., Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002, 2:11-17.
20. Watson C., Alp N.J. Role of Chlamydia pneumoniae in atherosclerosis. Clin Sci (Lond) 2008, 114:509-531.
21. Kozarov E.V., Dorn B.R., Shelburne C.E., Dunn W.A., Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005, 25:e17-e18.
22. Maass M., Bartels C., Engel P.M., Mamat U., Sievers H.H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998, 31:827-832.
23. Gaetti-Jardim E., Marcelino S.L., Feitosa A.C., Romito G.A., Avila-Campos M.J. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009, 58:1568-1575.
24. Kalayoglu M.V., Byrne G.I. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998, 66:5067-5072.
25. Lakio L., Lehto M., Tuomainen A.M., Jauhiainen M., Malle E., Asikainen S., et al. Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin Res 2006, 12:57-64.
26. Belland R.J., Ouellette S.P., Gieffers J., Byrne G.I. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004, 6:117-127.
27. Pussinen P.J., Paju S., Mantyla P., Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007, 14:2402-2412.
28. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
29. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 1999, 274:32512-32519.
30. Stocker C.J., Sugars K.L., Harari O.A., Landis R.C., Morley B.J., Haskard D.O. TNF-{alpha}, IL-4, and IFN-{gamma} Regulate differential expression of P- and E-Selectin expression by Porcine aortic endothelial cells. J Immunol 2000, 164:3309-3315.
31. Wellicome S., Thornhill M., Pitzalis C., Thomas D., Lanchbury J., Panayi G., et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990, 144:2558-2565.
32. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989, 59:1203-1211.
33. Tonetti M.S., D'Aiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007, 356:911-920.
34. Pischon N., Hagewald S., Kunze M., Heng N., Christan C., Kleber B.M., et al. Influence of periodontal therapy on the regulation of soluble cell adhesion molecule expression in aggressive periodontitis patients. J Periodontol 2007, 78:683-690.
35. Kaukoranta-Tolvanen S.S., Ronni T., Leinonen M., Saikku P., Laitinen K. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog 1996, 21:407-411.
36. Hyvarinen K., Tuomainen A.M., Laitinen S., Bykov I.L., Tormakangas L., Lindros K., et al. Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice. Infect Immun 2009, 77:3442-3449.
37. Ekman M.R., Grayston J.T., Visakorpi R., Kleemola M., Kuo C.C., Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993, 17:420-425.
38. Tormakangas L., Saario E., Bem David D., Bryskier A., Leinonen M., Saikku P. Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice. J Antimicrob Chemother 2004, 53:1101-1104.
39. van Haperen R., van Tol A., Vermeulen P., Jauhiainen M., van Gent T., van den Berg P., et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000, 20:1082-1088.
40. Damen J., Regts J., Scherphof G. Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta 1982, 712:444-452.
41. Pussinen P.J., Jauhiainen M., Vilkuna-Rautiainen T., Sundvall J., Vesanen M., Mattila K., et al. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res 2004, 45:139-147.
42. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-1353.
43. Hyvarinen K., Laitinen S., Paju S., Hakala A., Suominen-Taipale L., Skurnik M., et al. Detection and quantification of five major periodontal pathogens by single copy gene-based real-time PCR. Innate Immun 2009, 15:195-204.
44. Baranova I., Vishnyakova T., Bocharov A., Chen Z., Remaley A.T., Stonik J., et al. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 2002, 70:2995-3003.
45. Khovidhunkit W., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 2003, 44:1728-1736.
46. Zhou Y.F., Guetta E., Yu Z.X., Finkel T., Epstein S.E. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996, 98:2129-2138.
47. Cignarella A., Engel T., von Eckardstein A., Kratz M., Lorkowski S., Lueken A., et al. Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors. Atherosclerosis 2005, 179:229-236.
48. Hardardottir I., Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 1994, 5:207-215.
49. Pussinen P.J., Metso J., Malle E., Barlage S., Palosuo T., Sattler W., et al. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients. Biochim Biophys Acta 2001, 1533:153-163.
50. Sammalkorpi K., Valtonen V., Kerttula Y., Nikkila E., Taskinen M.R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988, 37:859-865.
51. Skretting G., Gjernes E., Prydz H. Regulation of lecithin:cholesterol acyltransferase by TGF-beta and interleukin-6. Biochim Biophys Acta 1995, 1255:267-272.
52. Malle E., Steinmetz A., Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993, 102:131-146.
53. van der Westhuyzen D.R., Cai L., de Beer M.C., de Beer F.C. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005, 280:35890-35895.
54. Artl A., Marsche G., Lestavel S., Sattler W., Malle E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 2000, 20:763-772.
55. de la Llera Moya M., Atger V., Paul J.L., Fournier N., Moatti N., Giral P., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994, 14:1056-1065.
56. Stoll L.L., Denning G.M., Weintraub N.L. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:2227-2236.
57. Kallio K.A.E., Buhlin K., Jauhiainen M., Keva R., Tuomainen A.M., Klinge B., et al. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun 2008, 14:247-253.
58. Schumacher A., Seljeflot I., Lerkerod A.B., Sommervoll L., Otterstad J.E., Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?. Clin Microbiol Infect 2002, 8:654-661.
59. Liuba P., Pesonen E., Paakkari I., Batra S., Andersen L., Forslid A., et al. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J Vasc Res 2003, 40:115-122.
60. Chou H., Yumoto H., Davey M., Takahashi Y., Miyamoto T., Gibson F.C., et al. Porphyromonas gingivalis Fimbria-dependent activation of inflammatory Genes in human aortic endothelial cells. Infect Immun 2005, 73:5367-5378.
61. Liuba P., Pesonen E., Paakkari I., Batra S., Forslid A., Kovanen P., et al. Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs. Atherosclerosis 2003, 167:215-222.
62. Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006, 116:59-69.
63. Aoki T., Kataoka H., Morimoto M., Nozaki K., Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 p.omote the progression of cerebral aneurysms in rats. Stroke 2007, 38:162-169.